Chung J H, Cho B Y, Lee H K, Kim T G, Han H, Koh C S
Department of Internal Medicine, Seoul National University College of Medicine, Korea.
J Korean Med Sci. 1994 Apr;9(2):155-61. doi: 10.3346/jkms.1994.9.2.155.
The localization and functional characteristics of tumor necrosis factor(TNF) beta gene raise the possibility that it may be involved in the susceptibility to autoimmune thyroid diseases. To investigate whether a TNF beta gene polymorphism is associated with autoimmune thyroiditis, we analyzed the TNF beta gene polymorphism with the restriction enzyme NcoI in 48 Korean patients with atrophic autoimmune thyroiditis [23 were found to be thyrotropin binding inhibitor immunoglobulin(TBII) positive, 25 TBII negative], 52 goitrous autoimmune thyroiditis, and 129 healthy controls. Two TNF beta alleles were identified from the restriction fragment length polymorphism studies of amplified genomic DNA. In atrophic autoimmune thyroiditis patients positive for TBII, 7 of 23 patients were homozygous for the TNF beta * 1 allele, 3 were homozygous for the TNF beta * 2 allele, and 13 were TNF beta * 1/2 heterozygous compared to controls(P = 0.20). Also, there were no associations between the TNF beta gene polymorphism and either TBII-negative atrophic autoimmune thyroiditis or goitrous autoimmune thyroiditis. Of the HLA-class II antigens, the frequency of HLA-DR8 was significantly greater among the 23 Korean patients with TBII-positive atrophic autoimmune thyroiditis compared to control subjects (Pc = 0.003). When the HLA-DR8 positive patients with TBII-positive atrophic autoimmune thyroiditis and controls were analyzed separately, the DR8 positive patients with TBII-positive atrophic autoimmune thyroiditis had more homozygotes for the TNF beta * 1 allele(6/12, 50.0%) and no homozygotes for the TNF beta * 2 allele, as compared to the DR8 negative patients with TBII-positive atrophic autoimmune thyroiditis and DR8 positive controls(P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
肿瘤坏死因子(TNF)β基因的定位和功能特性提示,该基因可能与自身免疫性甲状腺疾病的易感性有关。为研究TNFβ基因多态性是否与自身免疫性甲状腺炎相关,我们用限制性内切酶NcoI分析了48例韩国萎缩性自身免疫性甲状腺炎患者(其中23例促甲状腺素结合抑制性免疫球蛋白TBII阳性,25例TBII阴性)、52例甲状腺肿性自身免疫性甲状腺炎患者及129例健康对照者的TNFβ基因多态性。通过对扩增的基因组DNA进行限制性片段长度多态性研究,鉴定出两个TNFβ等位基因。在TBII阳性的萎缩性自身免疫性甲状腺炎患者中,23例患者中7例为TNFβ1等位基因纯合子,3例为TNFβ2等位基因纯合子,13例为TNFβ1/2杂合子,与对照组相比(P = 0.20)。此外,TNFβ基因多态性与TBII阴性的萎缩性自身免疫性甲状腺炎或甲状腺肿性自身免疫性甲状腺炎均无关联。在HLA - II类抗原中,23例TBII阳性的韩国萎缩性自身免疫性甲状腺炎患者中HLA - DR8的频率显著高于对照受试者(Pc = 0.003)。当分别分析TBII阳性的萎缩性自身免疫性甲状腺炎且HLA - DR8阳性的患者及对照时,与TBII阳性的萎缩性自身免疫性甲状腺炎且HLA - DR8阴性的患者及HLA - DR8阳性的对照相比,TBII阳性的萎缩性自身免疫性甲状腺炎且HLA - DR8阳性的患者中TNFβ1等位基因纯合子更多(6/12,50.0%),且无TNFβ*2等位基因纯合子(P < 0.05)。(摘要截短于250字)